Latest news
Iconovo signs agreement for development of inhaled oxytocin in ICOone for maternal health
Lund, December 21, 2020. Iconovo AB (publ) today announced that the company has signed a development agreement with Monash University for the development…
Iconovo’s collaboration with Stevanato marches on
Biostock published December 9th an article about Iconovo that can be found in its entirety below
Since entering a collaboration with the Italian healthcare…
Press releases
Aug 12, 2020, 15:54
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Aug 12, 2020, 15:54
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Jul 08, 2020, 19:57
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
Jul 08, 2020, 19:57
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Jul 02, 2020, 10:35
News
IR
English
Corporate Information
Other Corporate Information
Jul 02, 2020, 10:35
News
IR
Swedish
Corporate Information
Other Corporate Information
Jun 26, 2020, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Jun 26, 2020, 09:00
News
IR
English
Corporate Information
Other Corporate Information
Jun 24, 2020, 08:15
News
IR
English
Corporate Information
Other Corporate Information
Jun 24, 2020, 08:15
News
IR
Swedish
Corporate Information
Other Corporate Information
Jun 22, 2020, 10:35
News
IR
Swedish
Corporate Information
Other Corporate Information
May 28, 2020, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
May 26, 2020, 13:25
News
IR
Swedish
Corporate Information
Other Corporate Information
May 26, 2020, 13:25
News
IR
English
Corporate Information
Other Corporate Information
May 08, 2020, 15:09
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 08, 2020, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
May 01, 2020, 18:12
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
May 01, 2020, 18:12
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Apr 24, 2020, 18:10
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Apr 22, 2020, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se